Literature DB >> 23809103

Who's on first in exome and whole genome sequencing? Is it the patient or the incidental findings?

David S Rosenblatt1.   

Abstract

Entities:  

Keywords:  ACMG; Genetic screening; Genetic testing; Incidental findings; Whole exome sequencing; Whole genome sequencing

Mesh：

Year:  2013        PMID： 23809103     DOI： 10.1016/j.ymgme.2013.06.001

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN： 1096-7192            Impact factor:   4.797


× No keyword cloud information.
  8 in total

1.  Clinical tumor sequencing: an incidental casualty of the American College of Medical Genetics and Genomics recommendations for reporting of incidental findings.

Authors:  D Williams Parsons; Angshumoy Roy; Sharon E Plon; Sameek Roychowdhury; Arul M Chinnaiyan
Journal:  J Clin Oncol       Date:  2014-06-23       Impact factor: 44.544

Review 2.  Lysosomal diseases: diagnostic update.

Authors:  Bryan Winchester
Journal:  J Inherit Metab Dis       Date:  2014-04-08       Impact factor: 4.982

3.  A new approach to assessing affect and the emotional implications of personal genomic testing for common disease risk.

Authors:  Suzanne C O'Neill; Kenneth P Tercyak; Chanza Baytop; Sharon Hensley Alford; Colleen M McBride
Journal:  Public Health Genomics       Date:  2015-01-21       Impact factor: 2.000

4.  Utility of next generation sequencing in clinical primary immunodeficiencies.

Authors:  Nikita Raje; Sarah Soden; Douglas Swanson; Christina E Ciaccio; Stephen F Kingsmore; Darrell L Dinwiddie
Journal:  Curr Allergy Asthma Rep       Date:  2014-10       Impact factor: 4.919

5.  Perspectives on genetic and genomic technologies in an academic medical center: the duke experience.

Authors:  Sara Huston Katsanis; Mollie A Minear; Allison Vorderstrasse; Nancy Yang; Jason W Reeves; Tejinder Rakhra-Burris; Robert Cook-Deegan; Geoffrey S Ginsburg; Leigh Ann Simmons
Journal:  J Pers Med       Date:  2015-04-03

6.  The cost-effectiveness of returning incidental findings from next-generation genomic sequencing.

Authors:  Caroline S Bennette; Carlos J Gallego; Wylie Burke; Gail P Jarvik; David L Veenstra
Journal:  Genet Med       Date:  2014-11-13       Impact factor: 8.822

7.  Implications of using whole genome sequencing to test unselected populations for high risk breast cancer genes: a modelling study.

Authors:  Charlotte Warren-Gash; Mark Kroese; Hilary Burton; Paul Pharoah
Journal:  Hered Cancer Clin Pract       Date:  2016-06-01       Impact factor: 2.857

8.  Ethical Issues in Contemporary Clinical Genetics.

Authors:  Genna Braverman; Zachary E Shapiro; Jonathan A Bernstein
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2018-05-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.